Tonghua Golden-Horse Pharmaceutical Industry – World Class Benchmarking
Company: Tonghua Golden-Horse Pharmaceutical Industry Company Limited
Bloomberg ticker: 000766 SZ
Market cap: US$3,952m
Background: Tonghua Golden-Horse Pharmaceutical Industry Company Limited is a company focused on the development, production, and sale of pharmaceutical products. It specializes in both Traditional Chinese Medicine (TCM) and Western medicine, with a focus on oncology, rheumatology, and digestive health. It operates primarily in China.
World Class Benchmarking of Tonghua Golden-Horse Pharmaceutical Industry
- Profitable Growth rank of 7 was up compared to the prior period’s 8th rank.
- This is below average performance compared to 340 medium Health Care companies worldwide.
- Profitability rank of 7 was worse than its Growth rank of 6.
- Profitability rank of 7 was up compared to the prior period’s 8th rank.
- This is below average performance compared to peers.
- Growth rank of 6 was the same compared to the prior period’s 6th rank.
- This is below average performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.